|
End-of-day quote
Nasdaq
19/08/2026
|
5-day change | 1st Jan Change | ||
| 0.2700 USD | -8.66% |
|
-15.62% | -68.94% |
| 06-23 | Alps Group Inc Launches Patient-Derived Organoid Program To Advance Personalized Cancer Care In Southeast Asia | CI |
| 05-20 | Alps Group Gets Nasdaq Non-Compliance Notice | MT |
Chart: Technical Analysis
Stock exchange
Nasdaq
ALPS 0.2700 $
-8.66%
16.06K
$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
Nasdaq
| ALPS | 0.2700USD | -8.66% | 16.06K $ | |
OTC Markets
| ALPS | 0.3150USD | -1.56% | 31.44K $ | |
CBOE
| ALPS | 0.3198USD | +3.53% | 63.96 $ |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 0.3674 | 0.5 | 1.54 |
| Spread/Res. | -26.51% | -46.00% | -82.47% |
| Spread/Supp. | -0.00% | -0.00% | +177.49% |
| Support | 0.27 | 0.27 | 0.0973 |
- Stock Market
- Stocks
- ALPS Stock
- Charts Alps Group Inc
Select your edition
All financial news and data tailored to specific country editions

















